CompletedNCT04051138Updated Jan 27, 2021

The Effect of VOXX/eSmartr High Performance Technology on Sports Vision Ability

An interventional study of Voxx socks and sleeves in Vision, Binocular and Sports Medicine, sponsored by ChampionsEdge, LLC. Completed at 1 site in United States. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-01-27.

Sponsored by ChampionsEdge, LLC · Not applicable, Interventional, and Supportive care

Phase: Not applicable
Study type: Interventional
Enrollment: 50
Allocation: Randomized
Ages: 18 Years to 45 Years
Sex: All

Study summary

This study is designed to compare the effect of Voxx/eSmartr technology on common measures of sports vision performance including (Hand-Eye Coordination/Reaction time, visual concentration and basic visual functions of size detection and contrast sensitivity). The study will be a randomized, prospective, double-blind design in order to determine the effect of this technology on a subject's sports vision ability.

Conditions studied

Vision, Binocular
Sports Medicine

In context

Lead sponsor

This is the only study on the registry with ChampionsEdge, LLC as lead sponsor.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 18 Years to 45 Years
Sexes eligible: All
Accepts healthy volunteers: Yes

Inclusion criteria

Female or Male age 18-45 years of age
Exercises at least once a week by self-report
Physically able to complete the HEC/RT test (e.g. no shoulder or arm discomfort or limitation

Exclusion criteria

Exclusion Criteria.

Member of a vulnerable population
Visual or physical condition which precludes performing the physical or visual testing (e.g. strabismus, double vision, shoulder or arm pain or injury)
Previous training in hand-eye coordination/reaction time or visual concentration
History of double vision or strabismus
Insufficient vision to drive an automobile in NY State

Study design

Phase: Not applicable
Primary purpose: Supportive care
Allocation: Randomized
Intervention model: Single group
Masking: Triple (Participant, Care provider, Investigator)
Enrollment: 50 participants (actual)

Interventions

OtherVoxx socks and sleeves
participants will be tested with a true device as well as with a placebo device

What researchers measure

Primary outcomes

CoreScore
A measure of visual function scored on a linear scale fro +5 to -5, more positive scores are better
Time frame: 1 day

Secondary outcomes

Hand-Eye Coordination/Reaction Time
A measure of how fast the subject reacts to a visual target with their hand, scored on milliseconds, faster the better
Time frame: 1 day
Neurotracker score
A measure of how correctly the subject can track multiple objects, scored from 0 to 5 with higher score being better
Time frame: 1 day

Study locations

1 site

SportsVisionNYC
New York, New York 10019, United States

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Jan 27, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT04051138
Lead sponsor: ChampionsEdge, LLC
Responsible party: Sponsor
First posted: Aug 9, 2019
Start date: Aug 15, 2019
Primary completion: Oct 30, 2019
Completion: Oct 30, 2019
Last update: Jan 27, 2021

Study contacts

Daniel M Laby, MD

principal investigator · ChampionsEdge, LLC

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion